Clinical trial

HCV Positive Heart Donors

NCT03382847

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-01-05

PhasePHASE4

Study timeline

Study start (actual)2018-01-05Date precision: day

Registry last updated2021-02-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Transplant with HCV positive donor, followed by surveillance and treatment of viremiaCOMBINATION_PRODUCT

Sponsors & collaborators

NYU Langone Healthlead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03382847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.